Solid Biosciences Inc. Stock Analysis & AI Score
Solid Biosciences Inc. (SLDB) has an ST Score of 52.3 (B-), driven by its Forecast (A) and held back by its Momentum (C). Analysts rate it Buy with a $20.50 price target (+174.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Solid Biosciences Inc. (SLDB) has an ST Score of 52.3 (B-), driven by its Forecast (A) and held back by its Momentum (C). Analysts rate it Buy with a $20.50 price target (+174.1% upside).
- Strongest
- ForecastA
- Weakest
- MomentumC
All factor grades
- ForecastA
- ValuationB+
- Financial StrengthB
- GrowthC+
- ProfitabilityC
- MomentumC
- Piotroski2/9
Contact
SLDB stock: frequently asked questions
What is SLDB's ST Score?
Solid Biosciences Inc. (SLDB) has an ST Score of 52.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SLDB a buy, hold, or sell?
Analysts rate SLDB a Buy, with a price target of $20.50 (+174.1% vs the current price). Our ST Score grades it B- (52.3/100). The ST Score is a data-driven signal, not a recommendation.
What are SLDB's factor grades?
Valuation B+, Profitability C, Financial Strength B, Momentum C, Growth C+, Forecast A.
What is SLDB's valuation grade?
Solid Biosciences Inc. (SLDB) earns a valuation grade of B+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SLDB's growth grade?
Solid Biosciences Inc. (SLDB) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SLDB's profitability grade?
Solid Biosciences Inc. (SLDB) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SLDB's financial strength grade?
Solid Biosciences Inc. (SLDB) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SLDB?
The average analyst price target for Solid Biosciences Inc. (SLDB) is $20.50 from 23 analysts, which is +174.1% versus the recent price of $7.48.
What is SLDB's Piotroski score?
Solid Biosciences Inc. (SLDB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.